Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis

NCT00471094 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

831

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophagitis

Interventions

DRUG: Ilaprazole
DRUG: Ilaprazole
DRUG: Ilaprazole
DRUG: Lansoprazole

Sponsor

Takeda